All About Parkinson’s Disease: Clinical Features, Management And Future Research - Dr Rahul Chawla Written By Dr Rahul Chawla10 April 2024 3:04 PM IST Parkinson's disease (PD) is considered as the second most common neurodegenerative disorder in adults over the age of 60 years. Parkinson's...
Medical Bulletin 26/October/2023 Isra Zaman26 Oct 2023 3:00 PM ISTHere are the top medical news of the day:Impact of maternal COVID-19 vaccination during pregnancy evaluated in large studyMaternal mRNA COVID-19...
Can a Chinese martial art slow Parkinson's Disease progression Isra Zaman26 Oct 2023 9:00 AM ISTNew research published in the Journal of Neurology Neurosurgery & Psychiatry suggests that Tai Chi, a Chinese martial art known for its slow,...
Evidence that Parkinson's starts in the gut reaffirmed in new study Written By Isra Zaman24 Aug 2023 9:30 AM ISTNew findings by Columbia researchers and graduate students are adding to evidence backing this hypothesis-and showing that what triggers initial...
Parkinson's Disease: Clinical Update Written By Dr. Kamal Kant Kohli11 April 2023 10:45 AM ISTParkinson's disease, the second most prevalent neurodegenerative disorder, is characterised by motor symptoms systematised in a traditional tetrad...
Zydus Amantadine ER Capsules gets USFDA okay Ruchika Sharma6 Oct 2022 2:00 PM ISTThe drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, India.
Bajaj healthcare unveils Magnesium L-Threonate in nutraceutical segment MD Bureau25 Feb 2022 1:12 PM ISTThe product is available in 500 mg capsules for oral administration.
Zydus Pharma bags USFDA nod for Pimavanserin Capsules Ruchika Sharma1 Jan 2022 11:15 AM ISTAhmedabad: Zydus Cadila's U.S. subsidiary Zydus Pharmaceuticals (USA) Inc. has received tentative approval from the US Food and Drug Administration...
Increased age at Menopause linked to lowered Parkinson's Risk: Study Written By MD Editorial Team8 Sept 2021 9:00 AM ISTAccording to a study based on genetic data, women who are older in menopause tend to be at lower risk for Parkinson's disease (PD). The findings were...
GSK, Alector enter USD 2.2 billion deal for Parkinson's, Alzheimer's drugs Ruchika Sharma5 July 2021 11:00 AM ISTUK: GlaxoSmithKline Plc and U.S. firm Alector Inc will together develop antibody-based treatments for Parkinson's, Alzheimer's and other similar...
Optimus Pharma Anti-Parkinson's drug Safinamide gets DCGI okay Ruchika Sharma27 April 2021 12:10 PM ISTHyderabad: Optimus Pharma has announced that it has received DCGI approval for its Anti-Parkinson's drug Safinamide. Safinamide is indicated as...
Low vitamin D linked to severe Parkinson's disease, finds study Written By Medha Baranwal1 Jan 2021 12:30 PM ISTItaly: Low levels of vitamin D negatively affect the progression of Parkinson's disease (PD), according to a recent study in the...
